| 摘要 |
FIELD: medicine, therapy, hematology. ^ SUBSTANCE: the present innovation deals with treating anemia of different genesis due to applying recombinant Epoietin Omega (EO) to obtain medicinal preparation for treating anemia in patients being insensitive to the action of Epoietin Alpha or Beta, or in those who have unfavorable side effects in case of injecting these epoietins. The present innovation provides efficient therapy of anemia without any side action. ^ EFFECT: higher efficiency of therapy. ^ 15 cl, 26 dwg, 10 ex, 4 tbl |
